The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Candidiasis, Vulvovaginal

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Candidiasis, Vulvovaginal


High impact information on Candidiasis, Vulvovaginal


Chemical compound and disease context of Candidiasis, Vulvovaginal


Anatomical context of Candidiasis, Vulvovaginal

  • SUMMARY: Instead of vulvovaginal candidiasis being caused by defective or dysfunctional CD4 T helper 1-type cell-mediated immune reactivity, data suggest that symptomatic vulvovaginal candidiasis is associated with an aggressive response by polymorphonuclear neutrophils, whereas protection appears to be innate and noninflammatory [13].

Gene context of Candidiasis, Vulvovaginal


Analytical, diagnostic and therapeutic context of Candidiasis, Vulvovaginal


  1. Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis. Droegemueller, W., Adamson, D.G., Brown, D., Cibley, L., Fleury, F., LePage, M.E., Henzl, M.R. Obstetrics and gynecology. (1984) [Pubmed]
  2. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. Goswami, D., Goswami, R., Banerjee, U., Dadhwal, V., Miglani, S., Lattif, A.A., Kochupillai, N. J. Infect. (2006) [Pubmed]
  3. Fluconazole for the treatment of candidiasis: 15 years experience. Cha, R., Sobel, J.D. Expert review of anti-infective therapy. (2004) [Pubmed]
  4. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. Sobel, J.D. N. Engl. J. Med. (1986) [Pubmed]
  5. A concentrated therapeutic regimen for vulvovaginal candidiasis. Robertson, W.H. JAMA (1980) [Pubmed]
  6. Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis. Little, C.H., Georgiou, G.M., Marceglia, A., Ogedgebe, H., Cone, R.E., Mazza, D. Infect. Immun. (2000) [Pubmed]
  7. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. De Bernardis, F., Agatensi, L., Ross, I.K., Emerson, G.W., Lorenzini, R., Sullivan, P.A., Cassone, A. J. Infect. Dis. (1990) [Pubmed]
  8. Single-dose tioconazole compared with 3-day clotrimazole treatment in vulvovaginal candidiasis. Stein, G.E., Gurwith, D., Mummaw, N., Gurwith, M. Antimicrob. Agents Chemother. (1986) [Pubmed]
  9. Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis. O-Prasertsawat, P., Bourlert, A. Sexually transmitted diseases. (1995) [Pubmed]
  10. Current therapy of vulvovaginitis. Rein, M.F. Sexually transmitted diseases. (1981) [Pubmed]
  11. A dose-response study with Monistat cream. Pasquale, S.A., Lawson, J., Sargent, E.C., Newdeck, J.P. Obstetrics and gynecology. (1979) [Pubmed]
  12. Patient acceptance of prefilled disposable vaginal applicator. LePage, M.E., Brown, D., Wells, J. Am. J. Obstet. Gynecol. (1988) [Pubmed]
  13. Immunity in vaginal candidiasis. Fidel, P.L. Curr. Opin. Infect. Dis. (2005) [Pubmed]
  14. Women's use of over-the-counter antifungal medications for gynecologic symptoms. Ferris, D.G., Dekle, C., Litaker, M.S. The Journal of family practice. (1996) [Pubmed]
  15. Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study. White, D.J., Vanthuyne, A., Wood, P.M., Ayres, J.G. Sexually transmitted infections. (2004) [Pubmed]
  16. Differential characterization of women with vulvar vestibulitis syndrome. Witkin, S.S., Gerber, S., Ledger, W.J. Am. J. Obstet. Gynecol. (2002) [Pubmed]
  17. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. Ozcan, S.K., Budak, F., Yucesoy, G., Susever, S., Willke, A. APMIS (2006) [Pubmed]
  18. Determinants of incident vulvovaginal candidiasis in human immunodeficiency virus-positive women. Shifrin, E., Matityahu, D., Feldman, J., Minkoff, H. Infectious diseases in obstetrics and gynecology. (2000) [Pubmed]
  19. Vulvovaginal candidiasis treated with clotrimazole cream in seven days compared with fourteen-day treatment with miconazole cream. Robertson, W.H. Am. J. Obstet. Gynecol. (1978) [Pubmed]
WikiGenes - Universities